Jump to content

Talk:Tofacitinib

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Deletion of alopecia content seems excessive

[edit]

[deletion of alopecia content] seems excessive if the content is supported by the sources ? Any objections or conditions to adding back ? - Rod57 (talk) 22:47, 30 January 2016 (UTC)[reply]

FDA approved for psoriatic arthritis

[edit]

Tofacitinib for PsA: From Phase III to Approval - In mid-December, tofacitinib was approved for use in active psoriatic arthritis says FDA approved it for psoriatic arthritis in Dec 2017. - Rod57 (talk) 12:43, 29 December 2017 (UTC)[reply]

Still needs update?

[edit]

Anyone know what the February 2017 update request was about, and whether it was fulfilled or not? Myoglobin (talk) 17:15, 24 January 2018 (UTC)[reply]

Not sure why this tag was added, but as tofacitinib is approved now, it should contain information about contraindications, interactions, pharmacokinetics, and probably a more extensive side effects section (see MOS:MED#Drugs, treatments, and devices). Some long-term editors would also argue for removing information about (phase 2) studies. Also, the article seems to say that the drug isn't approved in the EU, which isn't true now [1]. --ἀνυπόδητος (talk) 18:39, 24 January 2018 (UTC)[reply]